Inducing Self-Dehumanization to Examine Oxytocin and Suicide Risk
NCT06710964 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2025-10-14
Summary
The goal of this experiment is to further determine if self-dehumanization is a novel risk factor for suicide. This study will induce self-dehumanization using a novel experimental self-dehumanized future condition (i.e., a futuristic paradigm that likens the individual to a machine) and compare this group to a control group to analyze the pathway between higher perceptions of self-dehumanization, suicidal ideation, and changes in oxytocin concentrations.
It is hypothesized that participants randomly assigned to the self-dehumanized mechanistic future condition will exhibit temporary increases in suicidal ideation (which will be thoroughly assessed, intervened upon following the induction) and decreases in oxytocin concentrations as compared to the control condition, which will not display significant changes. Further, we will explore if the magnitude of the oxytocin response will partially mediate the change in suicidal ideation.
Conditions
- Mechanistic Self-Dehumanization Condition
- Control Condition
Interventions
- OTHER
-
The Ten Item Personality Inventory
The Ten Item Personality Inventory (TIPI) is a brief self-report measure of the Big Five personality dimensions, which will provide the mock basis for the self-dehumanization induction. Participants will indicate responses on 7-point Likert scale ranging from 1 ("disagree strongly") to 7 ("agree strongly"). Building off previously validated tasks participants will be told that the TIPI measure provided certain information about their personalities (and therefore expectations for their future). To establish credibility, participants will receive accurate feedback surrounding their reported levels of extraversion (high, medium, low). Participants will be randomly assigned to receive one of the following pre-written, feedback scripts as additional implications about their extraversion scores in relationship to future social expectations.
- OTHER
-
Mechanistic Self-Dehumanization Condition
Future Mechanistic Self-Dehumanization Script: "Based on your responses, you're the type who will feel at times that you're just a number in the system. The day-to-day pattern of going to work and fulfilling responsibilities will seem repetitive, like you are a mechanical device just going through the motions. You might find that relationships feel distant or lack the warmth you seek, making it challenging to form deeper connections. Over time, each day will blend into the next, which will likely lead to you operating on autopilot, existing among humans."
- OTHER
-
Debrief
Debrief: Those in the self-dehumanized condition will receive a brief rehumanization intervention to undo the effects of the self-dehumanized condition. This intervention will involve a reminder that the condition was fabricated and will involve reading quotes involving general themes of humanness. The participants will then share with the experimenter how they connect to their humanness. The experimenter will document responses and encourage engagement in humanizing activities following the study visit. Findings from these qualitative responses will inform a rehumanization intervention in another study.
- OTHER
-
Control Condition
Future Control Script: "Based on your responses, you're the type who will have a very normal life. You will wake up, go to your job during the weekdays, and complete all necessary tasks. On the weekends you will spend time doing fulfilling activities. Relationships will have natural ups and down, but overall, you will feel satisfied by your connectedness to others. Though some days may feel monotonous, you will feel relaxed knowing you belong."
- DIAGNOSTIC_TEST
-
Clinical Interview
Clinical Interview. Self-Injurious Thoughts and Behaviors Interview-Short Form (SITBI-SF). Participants will complete an in-person interview featuring 72-items about their history of self-injury and suicidal behaviors. This interview includes 6 yes/no style questions about suicidal thoughts, suicidal plans, suicidal gestures, suicidal attempts, nonsuicidal self-injury thoughts, and nonsuicidal self-injury. Each category that is endorsed, across the lifetime, has follow up questions surrounding times, duration, intensity, severity, type, and if medical attention was sought. This interview has sound psychometric properties.
- OTHER
-
Self-Report Measures
Depressive Symptom Index - Suicidality Subscale (DSI-SS). Patient Health Questionnaire-8 (PHQ-8). Interpersonal Needs Questionnaire (INQ). Self-Dehumanization Scale (SDS).
- OTHER
-
Blood Draw
Five milliliters of blood will be drawn before and after study interventions for the quantification of plasma oxytocin concentrations by certified phlebotomists. Samples will be collected into chilled Ethylenediaminetetraacetic Acid (EDTA) tubes, inverted ten times to mix with anticoagulants, and centrifuged at 1600g for 15 minutes at 4˚C. Cleared plasma will be aliquoted into cryotubes and stored at -80˚C. Consistent with expert recommendations, oxytocin levels will be obtained from the samples diluted 1:4 (i.e., oxytocin can be discarded through plasma proteins when incorporating an extraction step before conducting the enzyme-linked immunosorbent assay \[ELISA\]). Second, to buffer against contrasting concerns, an aliquot of each sample will be analyzed for test-retest purposes. Oxytocin concentrations will be measured using a validated commercially available and sensitive ELISA neurophysin kit (Abcam).
Sponsors & Collaborators
-
Florida State University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2027-08-31
- Completion
- 2028-08-31
Countries
- United States
Study Locations
More Related Trials
-
Neuroendocrine Risk for PTSD in Women
NCT03973229 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Relationship Between Oxytocin Level, Trust, and Attachment in Individuals With Borderline Personality Disorder
NCT06045650 ·Status: NOT_YET_RECRUITING
-
Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study
NCT02508103 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Sex- and Context-dependent Effects of Oxytocin on Social Reward Processing
NCT03085628 ·Status: UNKNOWN ·Phase: NA
-
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
NCT05282277 ·Status: RECRUITING ·Phase: PHASE4
-
Perimenopausal Effects of Estradiol on Reward Responsiveness
NCT02255175 ·Status: COMPLETED ·Phase: PHASE4
-
Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)
NCT04902235 ·Status: COMPLETED ·Phase: PHASE4
-
Genderspecific Differences in Hormone Levels After Trauma
NCT05794256 ·Status: RECRUITING
-
Premenstrual Hormonal and Affective State Evaluation (PHASE) Project
NCT03862469 ·Status: COMPLETED ·Phase: NA
-
Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)
NCT00927095 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Reproductive Hormones on Mood and Behavior
NCT00001322 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hormones and Decision Making
NCT04865562 ·Status: COMPLETED ·Phase: PHASE4
-
Study on Allopregnanolone and Depression in Perimenopausal Women
NCT05329779 ·Status: TERMINATED ·Phase: PHASE4
-
The Effects of Sex Hormones on Cognition and Mood in Older Adults
NCT00000175 ·Status: TERMINATED ·Phase: NA
-
Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression
NCT06610305 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Testosterone in Women With Depression
NCT00676676 ·Status: COMPLETED ·Phase: NA
-
Brain Blood Flow Responses to Stress: Sex Differences
NCT06253702 ·Status: COMPLETED ·Phase: PHASE4
-
Neuroendocrine Dysfunction in Traumatic Brain Injury: Correlation With Cognitive Dysfunction and Repair
NCT00336726 ·Status: TERMINATED
-
Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)
NCT05319301 ·Status: COMPLETED ·Phase: NA
-
The Effect of 21-Days Intranasal Oxytocin on Patients With Post Traumatic Stress Disorder (PTSD)
NCT02336568 ·Status: UNKNOWN ·Phase: PHASE4
-
Testosterone Antidepressant Augmentation in Women
NCT01783574 ·Status: COMPLETED ·Phase: NA
-
Stress Hormones and IUDs
NCT03499379 ·Status: COMPLETED
-
Oxytocin and Reward Processing in Women
NCT06222749 ·Status: RECRUITING ·Phase: NA
-
Gonadal Steroid Manipulation and Personality Characteristics: Association With Mood Fluctuations and in Vitro Fertilization (IVF) Outcomes
NCT01032421 ·Status: COMPLETED
-
Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)
NCT00001770 ·Status: COMPLETED